Compugen (CGEN) PT Lowered to $14 at Oppenheimer
Tweet
Share
E-mailGet Alerts CGEN Hot Sheet
Price: $2.49 +2.47%
Rating Summary:
10 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Rating Summary:
10 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 10 | New: 48
Join SI Premium – FREE
Oppenheimer analyst Mark Breidenbach lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $17.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen™ Platform Update on October 5, 2026
- Singapore Telecommunications Ltd. (ST:SP) (SGAPY) PT Lowered to SGD4.98 at Macquarie
- Suntec REIT (SUN:SP) PT Lowered to SGD1.40 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
